4//SEC Filing
Mehalik Daniella 4
Accession 0001062993-24-001252
CIK 0000806517other
Filed
Jan 23, 7:00 PM ET
Accepted
Jan 24, 5:21 PM ET
Size
7.9 KB
Accession
0001062993-24-001252
Insider Transaction Report
Form 4
Mehalik Daniella
Vice President - Finance
Transactions
- Award
Stock Option (Right to Buy)
2024-01-22+35,000→ 35,000 totalExercise: $3.40Exp: 2034-01-22→ Common Stock, $.005 Par Value (35,000 underlying) - Award
Stock Option (Right to Buy)
2024-01-22+70,000→ 70,000 totalExercise: $3.40Exp: 2034-01-22→ Common Stock, $.005 Par Value (70,000 underlying)
Footnotes (2)
- [F1]The option becomes exercisable with respect to 50% of the shares on January 22, 2025 and with respect to the remaining 50% on January 22, 2026.
- [F2]The option becomes exercisable, if at all, in two 35,000 share increments. The first increment of 35,000 shares becomes exercisable at the time the weighted average daily price of Psychemedics common stock on the Nasdaq Stock Market during any consecutive 60 calendar day period ending on or before January 22, 2027 shall have exceeded $5.50. The second increment of 35,000 shares becomes exercisable at the time the weighted average daily price of Psychemedics common stock on the Nasdaq Stock Market during any consecutive 60 calendar day period ending on or before January 22, 2028 shall have exceeded $6.50.
Issuer
PSYCHEMEDICS CORP
CIK 0000806517
Entity typeother
Related Parties
1- filerCIK 0002003597
Filing Metadata
- Form type
- 4
- Filed
- Jan 23, 7:00 PM ET
- Accepted
- Jan 24, 5:21 PM ET
- Size
- 7.9 KB